EnBio Holdings Inc

EnBio Holdings Inc maintains a capital structure with a debt-to-equity ratio of 1.01, indicating a balanced mix of debt and equity financing. The company's liquidity position is characterized by a current ratio of 1.99, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, EnBio reports a return on equity (ROE) of 4.28% and a return on assets (ROA) of 1.88%. These figures are below the typical thresholds for strong performance in the industrial services sector, indicating that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks if the segment faces headwinds. Looking ahead, EnBio's growth trajectory is modest, with no specific revenue growth projections provided in the available data. The company's capital expenditures for the period were -1,079,075,000 JPY, indicating a reduction in investment in long-term assets, which may affect future growth potential. The company's risk profile is marked by a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential challenges in maintaining liquidity without external financing. No dilution sources are identified in the available data, and the dilution risk is assessed as low. Recent financial filings and transcripts do not provide additional insights into the company's strategic direction or operational performance beyond what is disclosed in the financial snapshot. The company's last actual EPS was 55.90 JPY, and its last actual revenue was 10,668,080,000 JPY, according to analyst estimates.